These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27983562)

  • 1. Plasma Cytokine Levels in Relation to Neuropsychiatric Symptoms and Cognitive Dysfunction in Huntington's disease.
    Bouwens JA; van Duijn E; Cobbaert CM; Roos RA; van der Mast RC; Giltay EJ
    J Huntingtons Dis; 2016 Dec; 5(4):369-377. PubMed ID: 27983562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
    Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J
    Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning.
    Reedeker N; Van Der Mast RC; Giltay EJ; Van Duijn E; Roos RA
    Mov Disord; 2010 Aug; 25(11):1612-8. PubMed ID: 20629165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
    van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB;
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.
    Ringkøbing SP; Larsen IU; Jørgensen K; Vinther-Jensen T; Vogel A
    J Huntingtons Dis; 2020; 9(1):59-68. PubMed ID: 31658065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Course of irritability, depression and apathy in Huntington's disease in relation to motor symptoms during a two-year follow-up period.
    van Duijn E; Reedeker N; Giltay EJ; Eindhoven D; Roos RA; van der Mast RC
    Neurodegener Dis; 2014; 13(1):9-16. PubMed ID: 23948661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Performance and Apathy Predict Unemployment in Huntington's Disease Mutation Carriers.
    Jacobs M; Hart EP; Roos RAC
    J Neuropsychiatry Clin Neurosci; 2018; 30(3):188-193. PubMed ID: 29325477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the association between apathy and deficits of social cognition and executive functions in Huntington's disease.
    Hendel RK; Hellem MNN; Hjermind LE; Nielsen JE; Vogel A
    J Int Neuropsychol Soc; 2023 May; 29(4):369-376. PubMed ID: 36189712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive impairment is associated with unawareness of neuropsychiatric symptoms in premanifest and early Huntington's disease.
    Andrews SC; Craufurd D; Durr A; Leavitt BR; Roos RA; Tabrizi SJ; Stout JC
    Neuropsychology; 2018 Nov; 32(8):958-965. PubMed ID: 30211612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopathology in verified Huntington's disease gene carriers.
    van Duijn E; Kingma EM; van der Mast RC
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):441-8. PubMed ID: 18070848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington's disease.
    Bouwens JA; Hubers AA; van Duijn E; Cobbaert CM; Roos RA; van der Mast RC; Giltay EJ
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1248-56. PubMed ID: 24957738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment.
    Kingma EM; van Duijn E; Timman R; van der Mast RC; Roos RA
    Gen Hosp Psychiatry; 2008; 30(2):155-61. PubMed ID: 18291297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers.
    Politis M; Lahiri N; Niccolini F; Su P; Wu K; Giannetti P; Scahill RI; Turkheimer FE; Tabrizi SJ; Piccini P
    Neurobiol Dis; 2015 Nov; 83():115-21. PubMed ID: 26297319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for cognitive dysfunction in Huntington's disease with the clock drawing test.
    Terwindt PW; Hubers AA; Giltay EJ; van der Mast RC; van Duijn E
    Int J Geriatr Psychiatry; 2016 Sep; 31(9):1013-20. PubMed ID: 26766850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irritability in Huntington's disease.
    Reedeker N; Bouwens JA; Giltay EJ; Le Mair SE; Roos RA; van der Mast RC; van Duijn E
    Psychiatry Res; 2012 Dec; 200(2-3):813-8. PubMed ID: 22537721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: the IMAGE-HD study.
    Gray MA; Egan GF; Ando A; Churchyard A; Chua P; Stout JC; Georgiou-Karistianis N
    Exp Neurol; 2013 Jan; 239():218-28. PubMed ID: 23123406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric aspects of Huntington's disease.
    Paulsen JS; Ready RE; Hamilton JM; Mega MS; Cummings JL
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):310-4. PubMed ID: 11511702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease.
    Andrews SC; Langbehn DR; Craufurd D; Durr A; Leavitt BR; Roos RA; Tabrizi SJ; Stout JC;
    Psychol Med; 2021 Jun; 51(8):1338-1344. PubMed ID: 32063235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.